Measurement of health-related quality of life in dermatological research and practice: Outcome of the EADV Taskforce on Quality of Life

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 10, 2013, Pages 1195-1203

  Prinsen, C A C ^a   De Korte, J ^a   Augustin, M ^b   Sampogna, F ^c   Salek, S S ^d   Basra, M K A ^e   Holm, E A ^f   Nijsten, T E C ^g  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^f Helsehuset   (Denmark)

^g ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CONSTRUCT VALIDITY; CONTENT VALIDITY; CRITERION RELATED VALIDITY; DERMATOLOGY; HUMAN; INTERNAL CONSISTENCY; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PSYCHOMETRY; QUALITY OF LIFE; RELIABILITY; REVIEW; TEST RETEST RELIABILITY; VALIDITY;

BIOMEDICAL RESEARCH; DERMATOLOGY; DISEASE MANAGEMENT; EUROPE; HEALTH STATUS; HUMANS; PSYCHOMETRICS; QUALITY OF LIFE; SEXUALLY TRANSMITTED DISEASES; SKIN DISEASES; VENEREOLOGY;

EID: 84884908680     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12090     Document Type: Review

References (56)

1. Cella DF, Tulsky DS,. Measuring quality of life today: methodological aspects. Oncology (Williston Park) 1990; 4: 29-38.
2. Siegrist J, Junge A,. Conceptual and methodological problems in research on the quality of life in clinical medicine. Soc Sci Med 1989; 29: 463-468.
3. Sprangers MA,. Disregarding clinical trial-based patient-reported outcomes is unwarranted: five advances to substantiate the scientific stringency of quality-of-life measurement. Acta Oncol 2010; 49: 155-163.
4. Testa MA, Simonson DC,. Assesment of quality-of-life outcomes. N Engl J Med 1996; 334: 835-840.
5. Valderas JM, Alonso J, Guyatt GH,. Measuring patient-reported outcomes: moving from clinical trials into clinical practice. Med J Aust 2008; 189: 93-94.
6. Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. U.S. Department of Health and Human Services, Washington, 2009.
7. Pathirana D, Ormerod AD, Saiag P, et al,. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23 (Suppl 2): 1-70.
8. Streiner DL, Norman GR,. Health Measurement Scales-A Practical Guide to Their Development and Use, 3rd edn. Oxford University Press, New York, 2003.
9. EuroQoL Group. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16: 199-208.
10. Brazier JE, Harper R, Jones NM, et al,. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305: 160-164.
11. Ware JE Jr, Sherbourne CD,. The MOS 36-item short-form health survey (SF-36) I Conceptual framework and item selection. Med Care 1992; 30: 473-483.
12. Hunt SM, McKenna SP, McEwen J, et al,. A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health 1980; 34: 281-286.
13. Hunt SM, McEwen J, McKenna SP,. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985; 35: 185-188.
14. Hunt S, McEwen J, McKenna S,. Measuring Health Status. Croom Helm, London, 1986.
15. Bergner M, Bobbitt RA, Carter WB, et al,. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787-805.
16. The WHO Group. Development of the WHOQOL: rationale and current status. Int J Ment Health 1994; 23: 24-56.
17. The WHO Group. The world health organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998; 46: 1569-1585.
18. Rapp SR, Feldman SR, Exum ML, et al,. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-407.
19. De Korte J, Mombers FM, Sprangers MA, et al,. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol 2002; 138: 1221-1227.
20. Fayers PM, Machin D,. Quality of Life-Assessment, Analysis and Interpretation. John Wiley & Sons Ltd, Chichester, West Sussex, 2000: 1-404.
21. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
22. Morgan M, McCreedy R, Simpson J, et al,. Dermatology quality of life scales-a measure of the impact of skin diseases. Br J Dermatol 1997; 136: 202-206.
23. Anderson RT, Rajagopalan R,. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997; 37: 41-50.
24. Chren MM, Lasek RJ, Quinn LM, et al,. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-713.
25. Chren MM, Lasek RJ, Quinn LM, et al,. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 1997; 108: 103-107.
26. Chren MM, Lasek RJ, Flocke SA, et al,. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433-1440.
27. Nijsten TE, Sampogna F, Chren MM, et al,. Testing and reducing Skindex-29 using Rasch analysis: Skindex-17. J Invest Dermatol 2006; 126: 1244-1250.
28. Twiss J, Meads DM, Preston EP, et al,. Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis?. J Invest Dermatol 2012; 132: 76-84.
29. Balkrishnan R, McMichael AJ, Camacho FT, et al,. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 2003; 149: 572-577.
30. Lewis VJ, Finlay AY,. Two decades experience of the Psoriasis Disability Index. Dermatology 2005; 210: 261-268.
31. McKenna SP, Cook SA, Whalley D, et al,. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol 2003; 149: 323-331.
32. Whalley D, McKenna SP, Dewar AL, et al,. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol 2004; 150: 274-283.
33. Nicholson K, Abramova L, Chren MM, et al,. A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol 2007; 57: 213-221.
34. Salek MS,. Compendium of Quality of Life Instruments, vol. 1-9. John Wiley & Sons, Chichester, 2010.
35. Both H, Essink-Bot ML, Busschbach J, et al,. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol 2007; 127: 2726-2739.
36. Lohr KN, Aaronson NK, Alonso J, et al,. Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther 1996; 18: 979-992.
37. Sprangers MA, Cull A, Bjordal K, et al,. The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res 1993; 2: 287-295.
38. Kirshner B, Guyatt G,. A methodological framework for assessing health indices. J Chronic Dis 1985; 38: 27-36.
39. Terwee CB, Dekker FW, Wiersinga WM, et al,. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 2003; 12: 349-362.
40. Terwee CB, Bot SD, De Boer MR, et al,. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 34-42.
41. Lord FM, Novick MR,. Statistical Theories of Mental Test Scores. Addison-Welsley Publishing Company, Reading, MA, 1968.
42. Lord FM,. A Theory of Test Scores. Psychometric Monogr. 1952; 7.
43. Lord FM,. The relation of the reliability of multiple-choice tests to the distribution of item difficulties. Psychometrika 1952; 17: 181-194.
44. Rasch G,. Probabilistic Models for Some Intelligence and Attainment Tests. University of Chicago Press, Chicago, IL, 1960.
45. Tennant A, McKenna SP, Hagell P,. Application of Rasch analysis in the development and application of quality of life instruments. Value Health 2004; 7 (Suppl 1): S22-S26.
46. Prinsen CA, Lindeboom R, Sprangers MA, et al,. Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. J Invest Dermatol 2010; 130: 1318-1322.
47. Prinsen CA, Lindeboom R, de Korte J,. Interpretation of Skindex-29 scores: cutoffs for mild, moderate, and severe impairment of health-related quality of life. J Invest Dermatol 2011; 131: 1945-1947.
48. Chren MM,. Interpretation of quality-of-life scores. J Invest Dermatol 2010; 130: 1207-1209.
49. Guyatt GH, Osoba D, Wu AW, et al,. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002; 77: 371-383.
50. Nijsten T, Sampogna F, Abeni D,. Categorization of Skindex-29 scores using mixture analysis. Dermatology 2009; 218: 151-154.
51. Hongbo Y, Thomas CL, Harrison MA, et al,. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.
52. Guillemin F, Bombardier C, Beaton D,. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417-1432.
53. Price VE, Klaassen RJ, Bolton-Maggs PH, et al,. Measuring disease-specific quality of life in rare populations: a practical approach to cross-cultural translation. Health Qual Life Outcomes 2009; 7: 92.
54. Basra MK, Fenech R, Gatt RM, et al,. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997-1035.
55. Nijsten T,. Dermatology life quality index: time to move forward. J Invest Dermatol 2012; 132: 11-13.
56. Noerholm V, Groenvold M, Watt T, et al,. Quality of life in the Danish general population-normative data and validity of WHOQOL-BREF using Rasch and item response theory models. Qual Life Res 2004; 13: 531-540.